The relapse of hairy cell leukemia after a 32-year remission.
 The optimum therapy for hairy cell leukemia (HCL) is controversial.
 Dramatic responses to interferon-alpha and 2'-deoxycoformycin overshadow the established role of splenectomy in HCL, and patients currently can avoid surgery altogether.
 A case is presented of clinical remission lasting 32 years after splenectomy--a prolonged normal life, without medication or medical intervention.
 When relapse occurred, the patient's response to interferon-alpha was prompt and predictable.
 Prognostic variables are an important consideration at the time of diagnosis in predicting the response to splenectomy.
